Health Care

Business & Economics

New PRI Study Finds That High Prescription Drug Costs Are Not Driving Up U.S. Health Care Costs

A more realistic evaluation of U.S. prescription drug prices shows that high drug prices are not actually driving up health care costs overall, and reflect the higher U.S. health care costs compared to the rest of the world, according to a new report released today by the Pacific Research Institute. ...
California

Dear President Trump: Single-Payer Healthcare Is Still A Disastrous Idea

Single-payer healthcare is making a comeback. A new survey by Morning Consult/Gallup finds that 44 percent of American voters support universal, government-run healthcare. Meanwhile, two California state senators introduced the Healthy California Act in February, a bill that would create a single-payer system in the Golden State. Even some prominent ...
Drug Innovation

ISSUE BRIEF: Nevada Proposal To Regulate Excess Costs Are Price Controls By Another Name

Click here to download a copy of PRI’s Issue Brief Senate Bill 265 would require pharmaceutical firms to reimburse insurers for any “excess costs” associated with drugs for diabetes, which are defined as the excess costs over the highest price in other developed countries. The Fiscal Notes on SB 265 ...
Commentary

Scrap Obamacare Subsidies: Trump Could Protect The Constitution And Rejuvenate Congress’ Efforts To Replace This Law

President Trump has a new bargaining chip in the drive to repeal and replace Obamacare. He recently expressed willingness to end the law’s “cost-sharing reduction” subsidies — which reimburse insurers for covering out-of-pocket costs like deductibles and co-pays for low-income exchange enrollees — in order to bring Democrats back to ...
California

Could California Become The Next Canada for Health Care?

State Sen. Ricardo Lara didn’t move to Canada following Donald Trump’s win last November, but he visited last week. While touring a major research hospital in Toronto, he said he realized that American views on providing health care are becoming more Canadian. “One fundamental difference between the United States and ...
Commentary

Withholding CSR Funds Could Push More Health Plans Out

If President Trump follows through with his suggestion that he might withhold subsidy payments to insurers as a way to force Democrats to the negotiating table, the move might have little effect on his political opponents but push struggling health plans out of the ACA marketplace. The president indicated in ...
Commentary

HHS Can Target Obamacare’s Medical Loss Ratio Rule Right Away

The legislative effort to repeal and replace Obamacare is on hold until Congress returns from recess. In the meantime, the executive branch can do its part to dismantle the health law’s most destructive components. The Trump administration can start by modifying Obamacare’s “medical loss ratio” rules, which dictate how insurers ...
Commentary

Republicans Are The Real Defenders Of Medicaid Patients

Is Obamacare’s survival as of now a victory for the nation’s poor? That’s what the law’s supporters would have people believe. Democrats — and more than a few Republicans — maintain that House Speaker Paul Ryan’s decision to withdraw the American Health Care Act on March 24 has saved millions ...
Commentary

Hospital Impact: In GOP’s Next Stab At Healthcare Reform, It Must Go Back To Basics

Although Congress failed to agree on a plan for repealing and replacing the Affordable Care Act before leaving for Easter recess, the GOP’s healthcare reform effort is hardly over. Republicans looking to avoid the mistakes that brought down their first attempt at reform—the American Health Care Act—would do well to ...
Commentary

The Good, The Bad, And The NICE: A Cautionary Tale For Government Negotiation

One of the cornerstones of Great Britain’s National Health Service is an agency that approves and controls access to prescription drugs, the National Institute for Health and Care Excellence. NICE recently announced a new policy that could delay and restrict access to new medicines for British citizens if the agency ...
Business & Economics

New PRI Study Finds That High Prescription Drug Costs Are Not Driving Up U.S. Health Care Costs

A more realistic evaluation of U.S. prescription drug prices shows that high drug prices are not actually driving up health care costs overall, and reflect the higher U.S. health care costs compared to the rest of the world, according to a new report released today by the Pacific Research Institute. ...
California

Dear President Trump: Single-Payer Healthcare Is Still A Disastrous Idea

Single-payer healthcare is making a comeback. A new survey by Morning Consult/Gallup finds that 44 percent of American voters support universal, government-run healthcare. Meanwhile, two California state senators introduced the Healthy California Act in February, a bill that would create a single-payer system in the Golden State. Even some prominent ...
Drug Innovation

ISSUE BRIEF: Nevada Proposal To Regulate Excess Costs Are Price Controls By Another Name

Click here to download a copy of PRI’s Issue Brief Senate Bill 265 would require pharmaceutical firms to reimburse insurers for any “excess costs” associated with drugs for diabetes, which are defined as the excess costs over the highest price in other developed countries. The Fiscal Notes on SB 265 ...
Commentary

Scrap Obamacare Subsidies: Trump Could Protect The Constitution And Rejuvenate Congress’ Efforts To Replace This Law

President Trump has a new bargaining chip in the drive to repeal and replace Obamacare. He recently expressed willingness to end the law’s “cost-sharing reduction” subsidies — which reimburse insurers for covering out-of-pocket costs like deductibles and co-pays for low-income exchange enrollees — in order to bring Democrats back to ...
California

Could California Become The Next Canada for Health Care?

State Sen. Ricardo Lara didn’t move to Canada following Donald Trump’s win last November, but he visited last week. While touring a major research hospital in Toronto, he said he realized that American views on providing health care are becoming more Canadian. “One fundamental difference between the United States and ...
Commentary

Withholding CSR Funds Could Push More Health Plans Out

If President Trump follows through with his suggestion that he might withhold subsidy payments to insurers as a way to force Democrats to the negotiating table, the move might have little effect on his political opponents but push struggling health plans out of the ACA marketplace. The president indicated in ...
Commentary

HHS Can Target Obamacare’s Medical Loss Ratio Rule Right Away

The legislative effort to repeal and replace Obamacare is on hold until Congress returns from recess. In the meantime, the executive branch can do its part to dismantle the health law’s most destructive components. The Trump administration can start by modifying Obamacare’s “medical loss ratio” rules, which dictate how insurers ...
Commentary

Republicans Are The Real Defenders Of Medicaid Patients

Is Obamacare’s survival as of now a victory for the nation’s poor? That’s what the law’s supporters would have people believe. Democrats — and more than a few Republicans — maintain that House Speaker Paul Ryan’s decision to withdraw the American Health Care Act on March 24 has saved millions ...
Commentary

Hospital Impact: In GOP’s Next Stab At Healthcare Reform, It Must Go Back To Basics

Although Congress failed to agree on a plan for repealing and replacing the Affordable Care Act before leaving for Easter recess, the GOP’s healthcare reform effort is hardly over. Republicans looking to avoid the mistakes that brought down their first attempt at reform—the American Health Care Act—would do well to ...
Commentary

The Good, The Bad, And The NICE: A Cautionary Tale For Government Negotiation

One of the cornerstones of Great Britain’s National Health Service is an agency that approves and controls access to prescription drugs, the National Institute for Health and Care Excellence. NICE recently announced a new policy that could delay and restrict access to new medicines for British citizens if the agency ...
Scroll to Top